Comparative Effectiveness of Intratympanic Corticosteroids Versus Antibiotics in the Treatment of Meniere's Disease: A Review Study
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 10 No. 1 (2024),
13 Esfand 2024
,
Page 1-7
https://doi.org/10.22037/orlfps.v10i1.46825
Abstract
Meniere's disease is an inner ear pathology characterized by recurrent episodes of vertigo, sensorineural hearing loss, a sensation of fullness in the ear, and tinnitus. It is estimated to occur at a rate of 15 individuals per 100,000 globally. Several recommendations exist for treating the disease, but there is no exact guideline to approach its management. In this study, we reviewed a decade of studies on the intratympanic approach to treating Meniere's disease which compared corticosteroids and antibiotics used on the condition. We found that the available data present conflicting evidence, and studies that investigated intratympanic gentamicin or dexamethasone did not demonstrate conclusive improvement in patient outcomes.
- Antibiotic; Intratympanic Injections; Meniere Disease; Corticosteroid.
How to Cite
References
Magnan J, Özgirgin ON, Trabalzini F, Lacour M, Escamez AL, Magnusson M, et al. European position statement on diagnosis, and treatment of Meniere’s disease. The journal of international advanced otology. 2018;14(2):317.
Alexander TH, Harris JP. Current epidemiology of Meniere's syndrome. Otolaryngologic Clinics of North America. 2010;43(5):965-70.
Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ. Prevalence, associated factors, and comorbid conditions for Meniere’s disease. Ear and hearing. 2014;35(4):e162-e9.
Jeng Y-J, Young Y-H. Comparison of inner ear deficits in Meniere’s variants and their significance. Acta Oto-Laryngologica. 2021;141(7):684-8.
Harcourt J, Barraclough K, Bronstein AM. Meniere’s disease. Bmj. 2014;349.
Mori N, Miyashita T, Inamoto R, Matsubara A, Mori T, Akiyama K, et al. Ion transport its regulation in the endolymphatic sac: suggestions for clinical aspects of Meniere’s disease. European Archives of Oto-Rhino-Laryngology. 2017;274:1813-20.
Phillips JS, Westerberg B. Intratympanic steroids for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews. 2011(7).
Postema RJ, Kingma CM, Wit HP, Albers FW, Van Der Laan BF. Intratympanic gentamicin therapy for control of vertigo in unilateral Meniere's disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta oto-laryngologica. 2008;128(8):876-80.
Lambert PR, Carey J, Mikulec AA, LeBel C, Group OMsS. Intratympanic Sustained-Exposure dexamethasone thermosensitive gel for symptoms of Ménière's disease: randomized phase 2B safety and efficacy trial. Otology & Neurotology. 2016;37(10):1669-76.
Piu F, Wang X, Fernandez R, Dellamary L, Harrop A, Ye Q, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otology & Neurotology. 2011;32(1):171-9.
Albu S, Chirtes F, Trombitas V, Nagy A, Marceanu L, Babighian G, et al. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease. American journal of otolaryngology. 2015;36(2):205-9.
Molnár A, Maihoub S, Tamás L, Szirmai Á. Intratympanically administered steroid for progressive sensorineural hearing loss in Ménière’s disease. Acta Oto-Laryngologica. 2019;139(11):982-6.
Al Attrache NA, Krstulovic C, Guillen VP, Pérez CM, Garrigues HP. Response over time of vertigo spells to intratympanic dexamethasone treatment in meniere’s disease patients. J Int Adv Otol. 2016;12(1):92-7.
Phillips J, Mikulec AA, Robinson JM, Skarinsky D, Anderson JJ. Efficacy of intratympanic OTO-104 for the treatment of Ménière's disease: the outcome of three randomized, double-blind, placebo-controlled studies. Otology & Neurotology. 2023;44(6):584-92.
Beyea JA, Instrum RS, Agrawal SK, Parnes LS. Intratympanic dexamethasone in the treatment of Meniere's disease: a comparison of two techniques. Otology & Neurotology. 2017;38(6):e173-e8.
Pradhan P, Lal P, Sen K. Long term outcomes of intratympanic Dexamethasone in intractable unilateral Meniere’s disease. Indian Journal of Otolaryngology and Head & Neck Surgery. 2019;71:1369-73.
Scarpa A, Ralli M, Cassandro C, Gioacchini FM, Alicandri-Ciufelli M, Viola P, et al. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results. American Journal of Otolaryngology. 2019;40(6):102289.
Bremer HG, van Rooy I, Pullens B, Colijn C, Stegeman I, van der Zaag-Loonen HJ, et al. Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy-results of a prematurely ended study. Trials. 2014;15:1-6.
Sam G, Chung DW, van der Hoeven R, Verweij S, Becker M. The effect of intratympanic gentamicin for treatment of Ménière’s disease on lower frequency hearing. International journal of clinical pharmacy. 2016;38:780-3.
Huon L-K, Fang T-Y, Wang P-C. Outcomes of intratympanic gentamicin injection to treat Meniere’s disease. Otology & Neurotology. 2012;33(5):706-14.
Pullens B, van Benthem PP. Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database of Systematic Reviews. 2011(3).
Huth M, Ricci A, Cheng A. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. International journal of otolaryngology. 2011;2011(1):937861.
O’Sullivan ME, Perez A, Lin R, Sajjadi A, Ricci AJ, Cheng AG. Towards the prevention of aminoglycoside-related hearing loss. Frontiers in cellular neuroscience. 2017;11:325.
Murch N. RATIONAL TESTING Mitochondrial DNA mutations predispose to aminoglycoside induced ototoxicity. BRITISH MEDICAL JOURNAL. 2012;345.
Foster II J, Tekin M. Aminoglycoside induced ototoxicity associated with mitochondrial DNA mutations. Egyptian Journal of Medical Human Genetics. 2016;17(3):287–93-–93.
Chaves BJ, Tadi P. Gentamicin. 2020. PMID: 32491482
King E, Shepherd R, Brown D, Fallon J. Gentamicin applied to the oval window suppresses vestibular function in guinea pigs. Journal of the Association for Research in Otolaryngology. 2017;18:291-9.
Yu J, Ding D, Wang F, Jiang H, Sun H, Salvi R. Pattern of hair cell loss and delayed peripheral neuron degeneration in inner ear by a high-dose intratympanic gentamicin. Journal of Otology. 2014;9(3):126-35.
Webster KE, Lee A, Galbraith K, Harrington-Benton NA, Judd O, Kaski D, et al. Intratympanic corticosteroids for Ménière’s disease. Cochrane Database of Systematic Reviews. 2023(2).
Patel M. Intratympanic corticosteroids in Ménière's disease: A mini-review. Journal of otology. 2017;12(3):117-24.
Hao W, Yu H, Li H. Effects of intratympanic gentamicin and intratympanic glucocorticoids in Meniere’s disease: A network meta-analysis. Journal of Neurology. 2022:1-15.
Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of Ménière’s disease. Otolaryngology--Head and Neck Surgery. 2016;154(5):824-34.
Oberman B, Patel V, Cureoglu S, Isildak H. The aetiopathologies of Ménière's disease: a contemporary review. Acta Otorhinolaryngologica Italica. 2017;37(4):250.
Rizk HG, Mehta NK, Qureshi U, Yuen E, Zhang K, Nkrumah Y, et al. Pathogenesis and etiology of Ménière disease: a scoping review of a century of evidence. JAMA Otolaryngology–Head & Neck Surgery. 2022;148(4):360-8.
- Abstract Viewed: 97 times
- PDF Downloaded: 67 times